STATE FATALITY SURVEILLANCE AND FIELD INVESTIGATIONS OF OCCUPATIONAL INJURIES: FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE) Release Date: December 14, 2000 RFA: OH-01-003 National Institute for Occupational Safety and Health Letter of Intent Receipt Date: January 12, 2001 Application Receipt Date: February 22, 2001 NOTE: Current FACE awardees should follow the instructions in the application kit for competing renewal applications (PHS 398, page 16, item C. Preliminary Studies/Progress Report). PURPOSE The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2001 funds for cooperative agreements to build State capacity for conducting traumatic occupational fatality surveillance, investigation and intervention activities using a fatality assessment and control evaluation (FACE) model. The objectives of this State- based program are to identify work environments that place workers at a high risk for fatal injury, identify the risk factors for these fatal injuries, and develop, disseminate and evaluate prevention strategies. The ultimate goal of this FACE program is to reduce the national burden for traumatic occupational fatalities through the development of effective prevention measures at the State and national level. Applications are sought that demonstrate a high potential for achieving these objectives. HEALTHY PEOPLE 2010 CDC is committed to achieving the health promotion and disease prevention objectives of Healthy People 2010, a national activity to reduce morbidity and mortality and improve the quality of life. This announcement is related to the focus area of Occupational Safety and Health. For information on the conference copy of Healthy People 2010, visit the internet site: http://www.health.gov/healthypeople. ELIGIBILITY REQUIREMENTS Applications may be submitted by State health and labor departments or by other State or territorial health agencies that have occupational safety and health responsibilities. This eligibility includes health departments or other official organizational authority (agency or instrumentality) of the District of Columbia, the Commonwealth of Puerto Rico, any territory or possession of the United States, and federally recognized Indian tribal governments, Indian tribes, or Indian tribal organizations. Applicants other than health or labor departments must apply in collaboration with and through their State and territorial health department. Awards will be limited to those organizations that can exercise public health authority for intervention into occupational safety and health problems. Program activities, however, may not be carried out by departmental divisions that are responsible for enforcement of occupational and health standards. Only one application per State will be accepted under this announcement. MECHANISM OF SUPPORT The administrative and funding instrument to be used for this program will be a cooperative agreement (U01), an assistance mechanism, in which substantial NIOSH scientific and/or programmatic involvement with the awardee is anticipated during performance of the activity. Under the cooperative agreement, the NIOSH purpose is to support and/or stimulate the recipient"s activity by involvement in and otherwise working jointly with the award recipient in a partner role. Details of the responsibilities, relationships and governance of the study to be funded under cooperative agreement(s) are discussed later in this document under the section Terms and Conditions of Award. The total project period for an application submitted in response to this present RFA may not exceed five (5) years. The anticipated award date is September 1, 2001. The award and level of support depends on receipt of applications of high scientific merit. Although this program is provided for in the financial plans of NIOSH, the award pursuant to this RFA is contingent upon the availability of funds for this purpose. AVAILABILITY OF FUNDS Approximately $600,000 is available in FY 2001 to make 4 - 6 awards under this RFA. For each award, the range of total costs (direct plus facilities and administration) per year is anticipated to be between $75,000 and $150,000 (maximum). Awards will be made for a 12-month budget period within a project period up to 5 years. Continuation awards within the project period will be made on the basis of satisfactory progress and availability of funds in future years. Use of Funds Applicants should allocate funds for travel to attend meetings as indicated in the section FACE Consortium and Coordination Committee (CC) Meetings. PREAPPLICATION CONFERENCE CALL Applicants are invited by NIOSH to participate in a preapplication technical assistance telephone conference call on January 22, 2001 at 1:00 PM (Eastern time) to discuss: programmatic issues regarding this program, how to apply, and questions regarding the content of the RFA. The conference name is Fatality Assessment and Control Evaluation (FACE) program. The telephone bridge number is 404-639-3277. Interested parties will need the conference code (679146) to participate. RESEARCH OBJECTIVES Background Traumatic occupational fatalities represent a public health problem of significant proportion. Based on data from the National Traumatic Occupational Fatalities (NTOF) surveillance system, there were over 94,000 occupational injury deaths in the United States for the period 1980-1995 [CDC, 1999]. Recent data from the Bureau of Labor Statistics documented 6,023 work- related injury deaths in 1999 [BLS, 2000]. Surveillance data such as NTOF and those from the Bureau of Labor Statistics are useful for setting research and prevention priorities as they identify common causes of death and worker groups experiencing large numbers and/or rates of occupational injury death. However, more in-depth information is frequently required to understand the circumstances and contributors to fatal injuries in order to develop effective preventive measures. The state-based FACE program began in 1983 within NIOSH to provide in-depth causal information on targeted types of work injury deaths. FACE was expanded in 1989 to multiple States to provide more timely and in-depth information than was available from existing surveillance systems with the goal of taking advantage of the individual State data to make national recommendations. State-based FACE programs permit the States to develop a network of organizations which voluntarily report occupational fatalities and link these surveillance activities to appropriate field investigations and to the development and dissemination of prevention strategies to those who could intervene in the workplaces within the State. In-depth, on-site investigations have been conducted on fatalities resulting from targeted causes of death that have included confined spaces, electrocutions, machine- related falls from elevation and logging. Numerous articles, monographs, hazard identifications and alerts have been written that detail findings on these targeted causes of death. In 1999, the in-depth on-site investigation targets were reassessed and revised to include deaths associated with machinery, deaths of youths under 18 years of age, and street/highway construction work zone fatalities. Purpose NIOSH seeks to build upon the past experience in state-based fatality surveillance to increase the base of knowledge to prevent work-related injury deaths nationwide in the currently identified priority areas as well as other occupations that may be identified as a result of data analysis or new prevention opportunities. Through an in depth analysis of data on interactions of the worker, the work environment, and work processes, prevention/intervention strategies aimed at reducing fatal injuries in the workplace can be developed. An integral part of this initiative is the establishment of a Fatality Assessment and Control Evaluation (FACE) Consortium. For this program, it is important that data elements which will be shared between awardees are managed in a uniform and compatible format. Because much of the shared data elements are centered on job tasks and workers, a critical role of the FACE Consortium will be to assure that the fatality data are uniform and comprehensive in order to achieve across state assessments. In addition, for the detailed investigations, the methods and data should have sufficient commonality to allow for analyses across the States as well as development of prevention recommendations. The FACE Consortium will establish a Coordination Committee (CC), comprised of one voting representative from each member of the consortium, to serve as the main governing board for the conduct of this research program. The CC will serve as an advisory body for the common or shared protocols to be used in the studies. NIOSH staff will serve as non- voting members of the CC. A Data Center may be established for this program through a competitive, peer- reviewed process. If established, each recipient will be responsible for providing data to the Data Center in a uniform fashion that is determined by the CC. This center will serve as the data resource for the analysis by the consortium investigators of the pooled data from all work sites in collaboration with the FACE Consortium. This Data Center will serve as a common repository for data, and these combined data will be available for all members of the FACE Consortium. Through the FACE Consortium, it is anticipated that critical risk factors for fatal traumatic occupational injuries will be better defined at both the State and national level, so that prevention and intervention strategies can be developed. It is anticipated that practitioners in occupational safety and health will be able to use the results from this project to more quickly and reliably discriminate job tasks that elevate risks for fatal traumatic injuries. With such knowledge, effective job design changes or interventions can be developed that reduce occupational traumatic fatalities. The FACE Consortium will combine the expertise and resources of NIOSH research staff with those of external collaborators. Individual investigators are encouraged to analyze and publish data on their respective work sites as soon as feasible. Objectives The ultimate goal of the FACE project is to reduce traumatic occupational fatalities within the States and throughout the nation. NIOSH seeks project applications that assist in building State capacity for conducting occupational fatality surveillance, on-site investigations, and for developing and disseminating hazard prevention strategies. The objectives of the State- based FACE project are to (1) identify work environments that place workers at high risk for fatal injury, (2) identify potential risk factors, and (3) formulate and disseminate prevention strategies to those who can intervene in the workplace. Applications are sought that demonstrate a high potential for implementing a balanced program that includes occupational fatality surveillance, field investigation of priority category fatalities, and development and dissemination of preventive strategies. Thus, applications which are responsive to the goals of this RFA should include detailed study plans for the following three areas. o A surveillance system to be used at the State level. This surveillance system should enable the State to identify all traumatic occupational fatalities occurring within the State in a timely fashion to allow investigation of targeted fatalities. The investigator should include plans for data management and quality control. o A plan for the conduct of on-site investigations on specific traumatic occupational fatalities. Investigators should include the rationale and criteria to be used for the selection of on-site investigations. Investigators are encouraged to consider the NIOSH FACE investigative model cited in the useful references section for guidance on the development of a traumatic occupational fatality protocol. o Development and evaluation of prevention strategies for reducing the incidence of traumatic occupational injuries and fatalities at the State level. USEFUL REFERENCES National Institute for Occupational Safety and Health. National Occupational Research Agenda. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No.96-115 (http://www.cdc.gov/niosh/nora.html). Morbidity and Mortality Weekly Report (MMWR). A Framework for Assessing the Effectiveness of Disease and Injury prevention. March 27, 1992/Vol.41/Jn. The MMWR can be accessed through the world-wide Web at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00016403.htm NIOSH FACE Program: National Institute for Occupational Safety and Health website at: http://www.cdc.gov/niosh/face/faceweb.html FACE CONSORTIUM AND COORDINATION COMMITTEE (CC) MEETINGS Applicants should include in their budget support for the PI and one other person from their institution integrally involved in the project to attend an annual program meeting of the FACE Consortium. The meeting will be of two or three days duration and will be held at a site mutually acceptable to study collaborators. The initial meeting will be in Morgantown, WV. The applicant should also budget for attendance by the PI at two CC meetings during the first year and two in each subsequent year. For budget preparation and project planning purposes, it should be assumed that these meetings will be held in Morgantown, WV. However, the CC will determine later where and when recurring CC meetings will be held. The CC chair will coordinate the meetings to review and assess overall progress and provide the opportunity for investigators to exchange information and discuss research issues. TERMS AND CONDITIONS OF AWARD The Terms and Conditions of Award, below, will be incorporated in all awards issued as a result of this RFA. It is critical that each applicant include specific plans for responding to these terms. These special Terms of Award are in addition to and not in lieu of otherwise applicable OMB administrative guidelines, HHS Grant Administration Regulations at 45 CFR Parts 74 and 92, and PHS Grants Policy Statement. Under the cooperative agreement, the NIOSH purpose is to support and/or stimulate the recipient"s activity by involvement in, and otherwise working jointly with, the award recipient in a partner role, but it is not to assume direction, prime responsibility, or a dominant role in the activity. Consistent with this concept, the dominant role and prime responsibility for the activity resides with the awardee(s) for the project as a whole, although specific tasks and activities in carrying out the studies will be shared among the awardees and the NIOSH collaborators where appropriate, including the following. 1. Recipient Responsibilities The recipient will coordinate project activities, scientifically and administratively, at the awardee institution and at the other sites that may be supported by sub-contractors to this award. The applicant will have primary authority and responsibility to define objectives and approaches, to plan, conduct, and analyze data, and to publish results, interpretations, and conclusions of studies conducted under the terms and conditions of the cooperative agreement award. In addition, the applicant is responsible for coordination of the individual study with the CC. Recipient will: a. identify and follow-up on occupational fatalities, b. use mechanisms to ensure that data collection and management procedures have necessary quality control and assure confidentiality of data, c. serve as a permanent member of the CC, d. submit semi-annual progress reports, e. collaborate in the scientific reporting of findings, f. provide program management oversight for the project, and g. Coordinate human subject clearances through external IRBs. 2. NIOSH Responsibilities NIOSH anticipates having substantial scientific programmatic involvement during conduct of this activity, through technical assistance, advice, and coordination. NIOSH will: a. serve as a scientific liaison between the awardee and other program staff at NIOSH with expertise in fatality assessment, b. provide advice on formats for data reporting and coding, computer software, and electronic storage of FACE surveillance and investigative data, c. provide expert consultation in the area of occupational fatality surveillance, epidemiology, on-site fatality investigation procedures, hazard identification, prevention strategies, and dissemination methods, if requested, d. provide technical assistance in identifying sentinel events resulting from industrial applications of new and emerging technologies, if requested, e. facilitate collaborative efforts to compile and disseminate program results through presentations and publications, and f. assist in the development of human subjects protocols for the CDC Institutional Review Board (if required) and in the preparation of OMB (and other) clearances that may be required during the conduct of the study. 3. Collaborative Responsibilities The CC will serve as the main governing board for the cooperative agreements making up the FACE Consortium. The principal investigator at the recipient organizations will have membership on the CC. NIOSH will have non-voting representation on the CC. Critical roles of the CC include ensuring that the study designs and data collection protocols are uniform and compatible across the FACE Consortium and developing broad-based measures and products to prevent fatal work injury. The CC may, when it deems necessary, invite additional, non-voting scientific advisors to the meetings at which research priorities and opportunities are discussed. A critical role of the CC will be the identification of sentinel events that should be investigated. It is anticipated that there will be two CC meetings during the first year and two in each subsequent year, but the actual number and locations of the meetings will be determined by the CC itself. The initial planning meeting will be organized by NIOSH and held in Morgantown, WV soon after the award, but subsequent meetings will be organized by the CC. The committee chair will schedule the meetings and will be responsible for developing the meeting agenda, chairing the meetings, and producing CC reports. At the Planning Meeting, the CC may: o discuss approaches for identifying fatal work injuries in a timely manner, o discuss and set initial targeted events to be investigated by the FACE Consortium, o identify potential end-users of investigation data and identify future products to be developed, and o establish data sharing mechanisms. At the second and subsequent meetings, the CC may: (1) make recommendations on the study protocols and data collection approaches, (2) discuss the targeted events that have been or will be investigated, (3) identify and recommend solutions to unexpected study problems and (4) discuss ways to efficiently coordinate and combine investigation data. HUMAN SUBJECTS REQUIREMENTS If a project involves research on human subjects, assurance (in accordance with Department of Health and Human Services Regulations, 45 CFR Part 46) of the protection of human subjects is required. In addition to other applicable committees, Indian Health Service (IHS) institutional review committees also must review the project if any component of IHS will be involved with or will support the research. If any American Indian community is involved, its tribal government must also approve that portion of the project applicable to it. Unless the grantee holds a Multiple Project Assurance, a Single Project Assurance is required, as well as an assurance for each subcontractor or cooperating institution that has immediate responsibility for human subjects. The Office of Human Research Protections (OHRP) negotiates assurances for all activities involving human subjects that are supported by the Department of Health and Human Services (Additional information is available at http://www.hhs.gov/ohrp/). INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the CDC to ensure that individuals of both sexes and the various racial and ethnic groups will be included in CDC-supported research projects involving human subjects, whenever feasible and appropriate. Racial and ethnic groups are those defined in OMB Directive No. 15 and include American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or other Pacific Islander. Applicants shall ensure that women, racial and ethnic minority populations are appropriately represented in applications for research involving human subjects. Where clear and compelling rationale exist that inclusion is inappropriate or not feasible, this situation must be explained as part of the application. This policy does not apply to research studies when the investigator cannot control the race, ethnicity, and/or sex of subjects. Further guidance to this policy is contained in the Federal Register, Vol. 60, No. 179, pages 47947-47951, and dated Friday, September 15, 1995. All investigators proposing research involving human subjects should read the UPDATED "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research," published in the NIH Guide for Grants and Contracts on August 2, 2000 (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-048.html), a complete copy of the updated Guidelines are available at http://grants.nih.gov/grants/funding/women_min/guidelines_update.htm: The revisions relate to NIH defined Phase III clinical trials and require: a) all applications or proposals and/or protocols to provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable, and b) all investigators to report accrual, and to conduct and report analyses, as appropriate, by sex/gender and/or racial/ethnic group differences. URLS IN NIOSH GRANT APPLICATIONS OR APPENDICES All applications must be self-contained within specified page limitations. Unless otherwise specified, internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the Internet sites. Reviewers are cautioned that their anonymity may be comprised when they directly access an Internet site. LETTER OF INTENT Prospective applicants are asked to submit by January 12, 2001, a letter of intent that includes a descriptive title of the proposed research, name, address, and telephone number of the Principal Investigator, identities of other key personnel and participating institutions, and number and title of the RFA in response to which the application may be submitted. Although a letter of intent is not required, is not binding, and does not enter into the review of subsequent applications, the information allows NIOSH staff to estimate the potential review workload and to avoid conflict of interest in the review. The letter of intent is to be sent to: Gwendolyn Cattledge, Ph.D., M.S.E.H. National Institute for Occupational Safety and Health Centers for Disease Control and Prevention (CDC) 1600 Clifton Road, N.E. Building 1, Room 3056, MS D-28 Atlanta, GA 30333 Telephone 404-639-2378 Fax 404-639-4175 Email: gcattledge@cdc.gov APPLICATION PROCEDURES Applicants must use Form PHS 398 (rev. 4/98). Application kits are available at most institutional offices of sponsored research and may be obtained from the Division of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892- 7910, telephone 301/710-0267, Email: grantsinfo@nih.gov. Application kits are also available at: http://grants.nih.gov/grants/forms.htm. The RFA label available in the PHS 398 (rev. 4/98) application form must be affixed to the bottom of the face page of the application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, the RFA title and number must be typed on line 2 of the face page of the application form and the YES box must be marked. Submit a signed original of the application, including the Checklist, and three signed photocopies, in one package to: Center for Scientific Review (CSR) National Institutes of Health 6701 Rockledge Drive, Room 1040 - MSC 7710 Bethesda, MD 20892-7710 Bethesda, MD 20817 (for express/courier service) At the time of submission, two additional copies of the application must also be sent to: Gwendolyn Cattledge, Ph.D., M.S.E.H. National Institute for Occupational Safety and Health Centers for Disease Control and Prevention (CDC) 1600 Clifton Road, N.E. Building 1, Room 3056, MS D-28 Atlanta, GA 30333 Telephone 404-639-2378 Fax 404-639-4175 Email: gcattledge@cdc.gov Applications must be received by February 22, 2001. If an application is received after that date, it will be returned to the applicant without review. CSR and NIOSH will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. CSR and NIOSH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of a substantial revision of an application already reviewed, but such an application must follow the guidance in the PHS Form 398 application instructions for the preparation of revised applications, including an introduction addressing the previous critique. REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed for completeness by CSR and responsiveness by NIOSH. Applications determined to be incomplete or unresponsive to this RFA will be returned to the applicant without further consideration. Those applications that are complete and responsive, will undergo further scientific merit review in accordance with the criteria stated below for scientific/technical merit by an appropriate peer review group convened by NIOSH. All applications will be judged on the basis of the scientific merit of the proposed project and the documented ability of the investigators to meet the RESEARCH OBJECTIVES of the RFA. Following the scientific review, competitive applications will be reviewed for programmatic importance by a NIOSH Secondary Review Committee. Scientific Review Criteria The review group will assess the scientific merit of the protocols and related factors as follows: Significance: Is the application relevant to the objectives outlined in the RFA? Has the applicant described the scope and nature of occupational fatalities in the applicant’s State? Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies? Approach: Does the application provide a plan and a proposed schedule for accomplishing each of the activities to be carried out in this project including the implementation of surveillance, on-site field investigations, dissemination and prevention components and a method for evaluating the accomplishments? Does the plan include a description of the methods the State will use to gain access to work sites for onsite investigations and secure or review pertinent information, as well as methods to facilitate collaboration with other State agencies involved in the investigation? Is there a plan for internal review of investigative reports and any other documents produced as a result of the program? Is there a plan to produce and disseminate fatality narrative reports, data, and other information that promotes the goals of increasing prevention activities? Is there an evaluation plan to assess the impact of the project on reducing targeted types of fatalities? Are the proposed schedule and personnel adequate for accomplishing the proposed activities? Does the applicant acknowledge potential problem areas and consider alternative approaches? Is the time line proposed for the project suitable? Investigators: Is the principal investigator and her/his collaborators appropriately trained and well suited to carry out this work? Do they have adequate experience and competence in surveillance activities? Do they have experience in conducting occupational traumatic injury investigations? Environment: Are the applicant’s facilities, equipment, and other resources adequate for the performance of this project? Is there evidence of institutional support generally, or specific agency commitment to development of occupational fatality surveillance, investigation, and dissemination activities? Are there letters of support or other documentation that demonstrates the applicant’s ability to work with diverse groups, establish linkages, and facilitate worker safety awareness information? Is there a commitment to share surveillance data with other States in the program so as to contribute to the goal of reducing fatalities across the nation? In addition to the above criteria, all applications will also be reviewed with respect to the following: o The reasonableness of the proposed budget and duration in relation to the proposed research. o The adequacy of plans to include both genders, minorities and their subgroups, for the scientific goals of the research. o The adequacy of the proposed protection for humans, animals or the environment, to the extent they may be adversely affected by the project proposed in the application. Programmatic Review Criteria: o Magnitude of the problem in terms of numbers of workers affected. o Likelihood of developing technical knowledge for the prevention of occupational safety hazards on a national, regional, or State basis. AWARD CONSIDERATIONS Applications will be considered for award based upon (a) scientific merit, (b) program importance, (c) program balance, and (d) availability of funds. SCHEDULE Letter of Intent Receipt Date: January 12, 2001 Application Receipt Date: February 22, 2001 Anticipated Award Date: September 1, 2001 INQUIRIES Inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. This RFA and other CDC Announcements can be found on the CDC HomePage (http://www.cdc.gov) under the Funding section (see Grants and Cooperative Agreements scroll down to Occupational Safety and Health). This RFA can also be found on the NIOSH HomePage (http://www.cdc.gov/niosh) under Extramural Programs, Current Funding Opportunities. Direct inquiries regarding programmatic issues to: Roy M. Fleming, Ph.D. Research Grants Program National Institute for Occupational Safety and Health Centers for Disease Control and Prevention 1600 Clifton Road, N.E. Building 1, Room 3053, MS D-30 Atlanta, GA 30333 Telephone: 404/639-3343 FAX: 404/639-4616 Email: rfleming@cdc.gov Direct inquiries regarding grants management to: Sheryl L. Heard, Grants Management Specialist Grants Management Branch, Procurement and Grants Office Centers for Disease Control and Prevention (CDC) 2920 Brandywine Road, Room 3000 Atlanta, Georgia 30341 Telephone: (770) 488-2723 Email address: slh3@cdc.gov PAPERWORK REDUCTION ACT Projects that involve the collection of information from 10 or more individuals and funded by cooperative agreement will be subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act. AUTHORITY AND REGULATIONS The Catalog of Federal Domestic Assistance number is: 93.262 for the National Institute for Occupational Safety and Health (NIOSH). This program is authorized under the Public Health Service Act, as amended, Section 301(a) [42 U.S.C. 241(a)], and the Occupational Safety and Health Act of 1970, Section 20(a) [29 U.S.C. 669(a)]. The applicable program regulation is 42 CFR Part 52. This program is subject to the intergovernmental review requirements of Executive Order 12372. LOBBYING RESTRICTIONS Applicants should be aware of restrictions on the use of HHS funds for lobbying of Federal or State legislative bodies. Under the provisions of 31 U.S.C. Section 1352, recipients (and their sub-tier contractors) are prohibited from using appropriated Federal funds (other than profits from a Federal contract) for lobbying congress or any Federal agency in connection with the award of a particular contract, grant, cooperative agreement, or loan. This includes grants/cooperative agreements that, in whole or in part, involve conferences for which Federal funds cannot be used directly or indirectly to encourage participants to lobby or to instruct participants on how to lobby. In addition, no part of CDC appropriated funds, shall be used, other than for normal and recognized executive-legislative relationships, for publicity or propaganda purposes, for the preparation, distribution, or use of any kit, pamphlet, booklet, publication, radio, television, or video presentation designed to support or defeat legislation pending before the Congress or any State or local legislature, except in presentation to the Congress or any State or local legislature itself. No part of the appropriated funds shall be used to pay the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence legislation or appropriations pending before the Congress or any State or local legislature. SMOKE-FREE WORKPLACE The CDC strongly encourages all grant and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.